Novel efficacy criteria for antitumor activity to immunotherapy using the example of ipilimumab, an anti-CTLA-4 monoclonal antibody Meeting Abstract
| Authors: | Hodi, F. S.; Hoos, A.; Ibrahim, R.; Chin, K.; Pehamberger, H.; Harmankaya, K.; O'Day, S.; Hamid, O.; Humphrey, R.; Wolchok, J. |
| Abstract Title: | Novel efficacy criteria for antitumor activity to immunotherapy using the example of ipilimumab, an anti-CTLA-4 monoclonal antibody |
| Meeting Title: | 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 26 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2008 May 30-Jun 3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2008-05-20 |
| Start Page: | 134s |
| Language: | English |
| ACCESSION: | WOS:000208457400747 |
| DOI: | 10.1200/jco.2008.26.15_suppl.3008 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 3008 -- Source: Wos |
